期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
AB044.Role of S100A16 and Annexin A4 proteins in maintaining membrane integrity
1
作者 Francis Noël Xiaolin Yan +1 位作者 Stefan Vetter Élodie Boisselier 《Annals of Eye Science》 2019年第1期219-219,共1页
Background:Maintaining the structural and functional integrity of membranes is essential for proper cells function.A recent proteomic study suggests that S100A16 and Annexin A4(ANXA4)proteins participate to maintain t... Background:Maintaining the structural and functional integrity of membranes is essential for proper cells function.A recent proteomic study suggests that S100A16 and Annexin A4(ANXA4)proteins participate to maintain the membrane integrity in the outer segment of the photoreceptors in the eye.The protein S100A16,recently discovered,is one of the S100 family proteins for which no protein and membrane interaction has yet been identified.Furthermore,maintain of the membrane integrity is calcium sensitive process.The main objective consists of studying the membrane interactions of S100A16 and ANXA4 proteins to better understand their functions in maintaining membrane integrity.Specific objectives are:(I)to achieve the purification of these proteins,(II)to gather information on their membrane interactions,and(III)to study the influence of calcium on these interactions.Methods:The S100A16 protein is obtained by cleavage followed by purification on a His-Trap column.Membrane interactions are studied with the Langmuir monolayer model.After measurement of the saturating concentration,the protein binding parameters,that to say the maximum insertion pressure and synergy,will then be determined in the presence of several phospholipids representative of physiological membranes.Results:The S100A16 protein was obtained with a purity greater than 99%and its saturating concentration is 0.5μM.Biophysical studies with different phospholipids in monolayer are currently in progress.Conclusions:Obtaining the S100A16 protein with a high purity allows carrying out the biophysical study in order to understand its membrane interactions.The purification of ANXA4 and the biophysical study with different phospholipids of this protein alone and in complex with the S100A16 protein will allow a better understanding of the membrane behavior of these proteins,as well as their roles in the maintenance of membrane integrity. 展开更多
关键词 S100A16 ANXA4 BIOPHYSICS LANGMUIR MONOLAYER
下载PDF
运动负荷试验阳性、血管造影证实冠状动脉狭窄的患者在采用连续递增运动方案和标准Bruce方案的运动试验中心肌缺血的不同阈值
2
作者 Noёl M. Jobin J. +2 位作者 Poirier P. P. Bogaty 黄欣 《世界核心医学期刊文摘(心脏病学分册)》 2007年第8期30-31,共2页
就血流动力学和气体交换参数而言,工作负荷的渐进性而非突然性增加所引起的反应更符合生理状态。因此,作者检测了与标准Bruce方案相比,采用连续递增运动方案是否会减轻冠状动脉疾病患者的心肌缺血程度。在18例具有心电图运动试验可重复... 就血流动力学和气体交换参数而言,工作负荷的渐进性而非突然性增加所引起的反应更符合生理状态。因此,作者检测了与标准Bruce方案相比,采用连续递增运动方案是否会减轻冠状动脉疾病患者的心肌缺血程度。在18例具有心电图运动试验可重复性缺血结果的男性冠心病患者中,比较了标准Bruce方案踏车试验和个体化ergocycle连续递增运动方案中的心电图缺血参数。 展开更多
关键词 BRUCE 运动负荷试验 运动试验 运动方案 踏车试验 男性冠心病 气体交换参数 血管造影 可重复性
下载PDF
AB095. Development of an assessment system of driver visual behaviours on a car simulator
3
作者 Josée Duquette Walter de Abreu Cybis +2 位作者 Isabelle Gélinas Geneviève Lize Marie-Chantal Wanet-Defalque 《Annals of Eye Science》 2018年第1期501-501,共1页
Background:(I)To describe the development and components of the automobile simulator driving behavior evaluation system developed by CRIR-Institut Nazareth et Louis-Braille;(II)to present the preliminary results of th... Background:(I)To describe the development and components of the automobile simulator driving behavior evaluation system developed by CRIR-Institut Nazareth et Louis-Braille;(II)to present the preliminary results of the content evaluation of the driving behavior evaluation grid.Methods:The evaluation system consists of five components:(I)the VS500M Car Simulator(Virage Simulation);(II)four VS500M driving scenarios,modified to minimize the occurrence of simulator sickness and expose subjects to commonly encountered driving situations on highways and city boulevards;(III)the Tobii Pro Glasses 2 eye tracking device;(IV)a car simulator driving behavior observation grid(DBOG);(V)a software application used during the behaviour evaluation phase,where synchronized video tracking,certain data from the simulator(e.g.,speed)and the DBOG grid are presented.Initially,the expected safe driving behaviors were identified,including 235 of a visual nature,supported by literature data and consultation of the project steering committee and an expert in driving assessment.Driving behaviors were assessed in 22 subjects without visual impairment(mean age 55±20 years).Subsequently,the items were revised to determine their relevance based on their importance in terms of road safety or on the frequency with which behaviors were observed among participants.For analysis purpose,the items of the DBOG were grouped according to their content,by type of expected driving behavior(e.g.,following a stop,look to the left and right before crossing the intersection)or element to be detected(e.g.,pedestrians).Results:Some visual behaviors are difficult to observe with the eye tracker device because they are more dependent on peripheral than central vision.Others are rarely observed,possibly because they are little or not realized in daily life or the representation of reality on the simulator does not stimulate their adoption.On the other hand,the visual detection behaviors expected in a situation where safety can be compromised are mostly carried out(e.g.,detection of oncoming vehicles,side mirror verification when changing lanes).Conclusions:This first phase of the study has made possible to better target the items to be kept in the car simulator driving behavior observation grid,and those that will have to be removed as they are too difficult to observe or too rarely adopted by the participants.Content validity and inter-rater reliability will be assessed from the simplified grid. 展开更多
关键词 Car driving simulator visual behaviours assessment tool
下载PDF
AB047.Membrane binding of S100A10 protein and AHNAK peptide involved in cell membrane repair
4
作者 Xiaolin Yan Marie-France Lebel-Beaucage +3 位作者 Samuel Tremblay Gary Shaw Dror Warschawski Élodie Boisselier 《Annals of Eye Science》 2019年第1期222-222,共1页
Background:The S100A10 protein might be an early biomarker of diabetes development leading to diabetic retinopathy.The protein complex S100A10/annexin A2 allows the recruitment of the C-terminal of AHNAK protein(AHNAK... Background:The S100A10 protein might be an early biomarker of diabetes development leading to diabetic retinopathy.The protein complex S100A10/annexin A2 allows the recruitment of the C-terminal of AHNAK protein(AHNAK C-ter peptide)to the membrane in presence of calcium,before forming a platform which can initiate membrane repair.However,no molecular data are currently available on membrane binding of the different proteins involved in this complex.We aim to study the membrane binding of S100A10,AHNAK C-ter peptide and their complex to better understand their roles in cell membrane repair process.Methods:Firstly,S100A10 will be overexpressed and purified by affinity chromatography and AHNAK C-ter peptide will be synthesized.Langmuir monolayers membrane model will then be used to characterize the interactions between these proteins and different phospholipids found in membranes.The secondary structure,orientation and membrane organization of these proteins will be studied by Polarization Modulation Infrared Reflection-Absorption Spectroscopy.Their lateral localization will be determined through the influence of these proteins on the physical state of lipids by fluorescence microscopy.Results:The optimization of the overexpression,purification and cleavage of the GST tag procedure to obtain pure S100A10 was completed.Protein identification by mass spectrometry and circular dichroism stability pre-studies were performed.In parallel,AHNAK C-ter peptide was studied by Langmuir monolayer model and the results indicate this peptide prefers lipids with negatively charged polar heads and unsaturated acyl chains.Preliminary solid-state NMR results confirm this phenomenon at 37℃.Conclusions:Our research will complete current knowledge on membrane binding of S100A10 and AHNAK C-ter peptide.We could also identify the conditions leading to modifications of these membrane bindings,and possibly to the loss of protein function.Thus,this project helps to better determine their roles in membrane repair,as well as in other physiological mechanisms in which these proteins are involved. 展开更多
关键词 S100A10 AHNAK diabetic retinopathy membrane repair
下载PDF
孕酮对脂肪细胞促酰化蛋白受体和下游信号蛋白表达的作用 被引量:1
5
作者 温宇 王宏伟 +4 位作者 胡秀芬 Katherine Cianflone 魏俊 夏治 李瑞珍 《中华医学杂志》 CAS CSCD 北大核心 2008年第2期114-118,共5页
目的观察孕酮对3T3-L1(前)脂肪细胞促酰化蛋白(ASP)受体C5L2 mRNA和细胞表面C5L2蛋白表达的影响,以及孕酮对ASP下游信号蛋白的作用。方法体外培养3T3-L1细胞,诱导细胞分化,不同浓度孕酮作用于3T3-L1(前)脂肪细胞,孵育过夜后... 目的观察孕酮对3T3-L1(前)脂肪细胞促酰化蛋白(ASP)受体C5L2 mRNA和细胞表面C5L2蛋白表达的影响,以及孕酮对ASP下游信号蛋白的作用。方法体外培养3T3-L1细胞,诱导细胞分化,不同浓度孕酮作用于3T3-L1(前)脂肪细胞,孵育过夜后收获细胞,分别采用RT-PCR和流式细胞仪检测ASP受体mRNA和蛋白表达情况;采用Western印迹法检测基础状态和ASP激发后Gαq/11,GB,p-PKCα和p-PKCζ蛋白表达。结果孕酮最大抑制成熟脂肪细胞14%C5L2 mRNA(P〉0.05)和蛋白表达22%(36%±15%vs46%±12%,P〈0.01),高浓度孕酮(1×10^-6mol/L)能显著性抑制前脂肪细胞66%C5L2 mRNA(0.17±0.11vs0.50±0.18,P〈0.01)和29%C5L2蛋白表达(36%±16%vs51%±20%,P〈0.05)。高浓度孕酮在一定程度上抑制ASP激发后成熟脂肪细胞Gαq/11,Gβ,p-PKCα和p-PKCζ的表达,各蛋白表达分别减少了41%(0.71±0.21vs1.20±0.24,P〈0.05),63%(0.55±0.32vs1.48±0.40,P〈0.05),49%(0.53±0.20vs1.04±0.19,P〈0.01)和32%(0.36±0.10vs0.53±0.20,P〉0.05)。在前脂肪细胞,高浓度孕酮显著性抑制ASP刺激的59%Gαq/11(0.42±0.18vs1.04±0.28,P〈0.01),43%Gβ(0.77±0.09vs1.35±0.27.P〈0.05),51%p—PKCα(0.44±0.15vs0.90±0.25,P〈0.05)和30%P-PKC((0.27±0.08vs0.39±0.12,P〈0.05)蛋白表达。结论孕酮诱导ASP抵抗的发生,ASP抵抗参与了高浓度孕酮引起的脂肪细胞胰岛素抵抗状态的病理生理过程。 展开更多
关键词 脂细胞 孕酮 胰岛素抵抗
原文传递
Effects of fatty acid regulation on visfatin gene expression in adipocytes 被引量:22
6
作者 WEN Yu WANG Hong-wei +3 位作者 WU Jing LU Hui-ling HU Xiu-fen Katherine Cianflone 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第20期1701-1708,共8页
Background The levels of long-term elevated serum or intracellular free fatty acid (FFA) induce insulin resistance associated with central obesity. The insulin-mimetic protein visfatin is preferentially produced by ... Background The levels of long-term elevated serum or intracellular free fatty acid (FFA) induce insulin resistance associated with central obesity. The insulin-mimetic protein visfatin is preferentially produced by visceral adipose tissues and has been implicated in obesity and insulin resistance. To identify that FFA is capable of inducing insulin resistance and to clarify the role of FFA on visfatin, we examined the effect of monounsaturated FFA oleate (C 18: 1) and saturated FFA palmitate (C 16:0) on glucose transport and visfatin gene expression in cultured 3T3-L1 adipocytes or preadipocytes.Methods FFA-free DMEM/F12, 0.125 mmol/L, 0.5 mmol/1 and 1.0 mmol/L oleate or palmitate was added to cultured 3T3-L1 adipocytes or preadipocytes and incubated overnight. Glucose transport was assessed as 3H- 2-deoxy-glucose uptake. Total RNA was extracted and subjected to RT-PCR for the measurement of visfatin mRNA levels. Statistical comparisons between control group and other groups were performed with the two-tailed paired t test, and one-way ANOVA was used to compare the mean values among the groups.Results Insulin increased specific membrane glucose transport in 3T3-L1 preadipocytes. Upregulation was evident from 15 minutes to 1 hour exposure to insulin. However, after 6-hour exposure to insulin, there was a downregulation in the response to insulin. Dose response studies demonstrated that 2-deoxy glucose transport was increased by 336% at 50 nmol/L insulin (P〈0.01), and reached a maximal effect at 100 nmol/L insulin (P〈0.01). Oleate and palmitate treatment did not influence basal glucose transport (without insulin stimulation), whereas insulin-stimulated glucose transport was inhibited after overnight oleate and palmitate treatment in preadipocytes and adipocytes. In 3T3-L1 preadipocytes, insulin resistance could be achieved at 0.125 mmol/L oleate or palmitate (P〈0.05, respectively), and the inhibition was dose dependent. In adipocytes, the inhibition was noted at 0.5 mmol/L oleate or 1.0 mmol/L palmitate. Visfatin mRNA expression increased during differentiation more than 1.5-fold. Bovine serum albumin (BSA) did not influence visfatin mRNA expression compared with the control group. Dose-response studies demonstrated that addition of 0.125 mmol/L oleate and palmitate to 3T3-L1 adipocytes decreased visfatin mRNA expression significantly (78%, 77%, respectively, relative to untreated control, P〈0.05), and further to 65% (relative to untreated control, P〈0.05) and 55% (relative to untreated control, P〈0.01) at 1.0 mmol/L FFA. Furthermore, the suppression on preadipocytes was similar to that of adipocytes, which reached a maximal reduction of 44% (oleate, P〈0.05) and 47% (palmitate, P〈0.05) at 1.0 mmol/L FFA.Conclusions Oleic acid and palmitic acid may induce insulin resistance in 3T3-L1 adipocytes and preadipocytes. Downregulation of visfatin mRNA may contribute to impair insulin sensitivity caused by oleate and palmitate. 展开更多
关键词 3T3-L 1 cells fatty acids nonesterified visfatins insulin resistance
原文传递
Pneumonectomy for chronic inflammatory lung disease: indications and complications 被引量:1
7
作者 NIE Gang LIU Guo-jun +1 位作者 Jean Deslauriers FAN Zhi-min 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第9期1216-1219,共4页
Chronic inflammatory lung disease is a common ,health problem and often treated with potent antibiotics, anti-tuberculosis drugs, and antifungal agents. However, in case of medical therapy failure, surgical treatment ... Chronic inflammatory lung disease is a common ,health problem and often treated with potent antibiotics, anti-tuberculosis drugs, and antifungal agents. However, in case of medical therapy failure, surgical treatment has been often considered as an effective procedure. Indications for surgical procedure mainly include recurrent infection, acute suppurative complications including lung abscess and empyema, and often chronic, intermittent, or massive hemoptysis.1 Segmentectomy or lobectomy is considered as an "ideal" procedure when the disease is localized to one lung and single segment or lobe. 展开更多
关键词 inflammatory lung disease PNEUMONECTOMY INDICATIONS COMPLICATIONS
原文传递
综述:应用心脏选择性β受体阻滞剂对慢性阻塞性肺病患者呼吸系统无不良影响
8
作者 Salpeter S Ormiston T +3 位作者 Salpeter E Yves Lacasse 刘毅(译) 代华平(校) 《英国医学杂志中文版》 2006年第6期374-375,共2页
关键词 慢性阻塞性肺病患者 呼吸系统症状 选择性Β受体阻滞剂 心脏 不良影响 综述 B受体阻滞剂 COCHRANE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部